NCT07683299

Brief Summary

HEMO-INTEGRA is a software system that integrates four domains of intraoperative hemodynamic monitoring in a single dashboard during cardiac surgery with cardiopulmonary bypass (CPB): (1) ventricular-arterial coupling (VAC) analysis using the Balan 2026 method; (2) tissue perfusion and oxygen delivery (EPOC module with Q10 temperature correction); (3) neuromonitoring (NIRS/BIS); and (4) systemic venous congestion assessment via VExUS-TEE (Waldron 2024 method). This pilot observational study evaluates the feasibility and completeness of data capture using HEMO-INTEGRA across five perioperative time points (T0: pre-CPB; T1: early CPB; T2: mid-CPB; T3: rewarming; T4: post-CPB) in adult patients undergoing elective cardiac surgery at Clinica Medellin Sede Occidente, Medellin, Colombia. The system operates in parallel with standard monitoring and does not modify clinical management. No additional procedures are performed on participants beyond standard of care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
7mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
May 2026Mar 2027

Study Start

First participant enrolled

May 27, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 27, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

June 27, 2026

Last Update Submit

June 27, 2026

Conditions

Keywords

HEMO-INTEGRAVExUSOxygen DeliveryNIRSDeep HypothermiaTransesophageal EchocardiographyClinical Decision Support

Outcome Measures

Primary Outcomes (1)

  • Data Capture Completeness

    Proportion of cases with complete data capture across all five intraoperative time points (T0 to T4) for all four HEMO-INTEGRA monitoring modules: ventricular-arterial coupling, tissue perfusion, neuromonitoring, and venous congestion assessment.

    Intraoperative (0 to 6 hours)

Study Arms (1)

HEMO-INTEGRA Cohort

Adult patients undergoing elective cardiac surgery with cardiopulmonary bypass monitored with the HEMO-INTEGRA integrated hemodynamic monitoring system across five intraoperative time points (T0 to T4). Intervention Name : HEMO-INTEGRA v2.0 Software system for integrated intraoperative hemodynamic monitoring integrating ventricular-arterial coupling (Balan 2026), tissue perfusion (EPOC/Q10), neuromonitoring (NIRS/BIS), and venous congestion (VExUS-TEE). Operates in parallel with standard care without modifying clinical management.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing elective cardiac surgery with cardiopulmonary bypass at Clinica Medellin Sede Occidente, Medellin, Colombia.

You may qualify if:

  • \- Adult patients 18 years or older scheduled for elective cardiac surgery with cardiopulmonary bypass
  • Standard intraoperative TEE and arterial line monitoring in place
  • Written informed consent obtained

You may not qualify if:

  • \- Emergency surgery
  • Off-pump cardiac surgery (OPCAB)
  • Inability to obtain adequate TEE window
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Medellin Sede Occidente

Medellín, Antioquia, Colombia

RECRUITING

Study Officials

  • Hernan D Castro-Arias, MD MSc

    Clinica Medellin Sede Occidente, Grupo Quiron Salud

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hernan D Castro-Arias, MD MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Cardiac Anesthesiologist and Principal Investigator

Study Record Dates

First Submitted

June 27, 2026

First Posted

July 6, 2026

Study Start

May 27, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

July 6, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to the pilot nature of this study and local institutional privacy regulations. Aggregate results will be reported in peer-reviewed publications.

Locations